Lupin share price rose 2.5% after the company received USFDA approval for new drug to treat overactive bladder
Lupin share price jumped nearly 2.5% to Rs 682 per share levels on the BSE intraday after the company received USFDA approval for Mirabegron Tablets or Generic Myrbetriq
Written By: Zee Business Video Team